Harf C, Welter R
Fortschr Med. 1984 Jun 21;102(23):647-52.
Isosorbide dinitrate (ISDN) was administered intravenously to 21 patients with severe cardiogenic pulmonary edema. In 15 cases the condition was due to coronary heart disease (3 of them had arterial hypertension additionally), and 3 patients due to cardiomyopathy. In the remaining 3 valvular disorders were prevailing. The ISDN solution was administered as an i.v. bolus followed by continuous i.v. injection from an automatic perfusion device. Oxygen, furosemide, and in some cases digitalis were given in addition. Monitoring consisted of clinical surveillance, blood gas analyses, and repeated X-ray control. The results obtained confirm the efficacy and safety of this mode of ISDN administration. This applies particularly for patients in whose therapy is aimed at fast control of life-threatening hypoxia. Despite extreme asphyxia, only three patients needed artificial respiration, one died in cardiogenic shock, while all others were rapidly improved. It could thus be demonstrated that this type of therapy may be safely and efficiently handled by careful clinical supervision, without invasive hemodynamic monitoring.
对21例严重心源性肺水肿患者静脉注射硝酸异山梨酯(ISDN)。其中15例病因是冠心病(3例还患有动脉高血压),3例病因是心肌病。其余3例以瓣膜性疾病为主。ISDN溶液以静脉推注给药,随后通过自动灌注装置持续静脉注射。此外还给予了氧气、呋塞米,部分病例还给予了洋地黄。监测包括临床观察、血气分析和多次X线检查。所获得的结果证实了这种ISDN给药方式的有效性和安全性。这尤其适用于旨在快速控制危及生命的低氧血症的患者治疗。尽管存在极度窒息,但仅3例患者需要人工呼吸,1例死于心源性休克,而其他所有患者均迅速好转。由此可以证明,这种类型的治疗在仔细的临床监督下可以安全有效地进行,无需有创血流动力学监测。